JPRN-UMIN000035328
Completed
未知
A multicenter retrospective study on the treatment and the prognosis of descending necrotizing mediastinitis - A multicenter retrospective study on descending necrotizing mediastinitis
Oita University, Department of Thoracic and Breast Surgery0 sites300 target enrollmentDecember 20, 2018
ConditionsDescending necrotizing mediastinitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Descending necrotizing mediastinitis
- Sponsor
- Oita University, Department of Thoracic and Breast Surgery
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who refused to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multicenter retrospective study of treatment with recombinant human soluble thrombomoduin (rTM) in severe acute pancreatitis with disseminated intravascular coagulation (DIC)acute pancreatitisJPRN-UMIN000031768Osaka Saiseikai Nakatsu Hospital department of gastroenterology and hepatology600
Not yet recruiting
Phase 1
A multi-center clinical study on the treatment of knee osteoarthritis with Qubi Yangge Decoction combined with three steps and nine methods of whole kneeITMCTR2000003608onghua Hospital, Shanghai University of Traditional Chinese Medicine
Recruiting
Not Applicable
Multicenter observational study on treatment results for rectal cancerRectal cancerJPRN-UMIN000040406Yokohama City University5,000
Not yet recruiting
Not Applicable
A Multicenter clinical research on the treatment of lumbar intervertebral disc herniation with nerve root adhesion with integrated traditional Chinese and minimally invasive spine surgerylumbar intervertebral disc herniationITMCTR2000003660Shuguang Hospital Affiliated to Shanghai University of TCM
Completed
Not Applicable
Multicentre Non-interventional Study of Treatment Outcome in Heart Failure Patients with Hyperkalaemia under RAASi-treatment Receiving Veltassa in Routine PracticeE87.5HyperkalaemiaDRKS00014825Vifor Pharma Deutschland GmbH22